The distinction between CVID and CID is extremely important, as a higher incidence of pneumonia, lymphoma, granulomas, autoimmunity, and enteropathy (2, 5, 123), in addition to lower B-cell and naive CD4 T-cell numbers, accounts for the lower 5-year survival rate in CID patients (123). This evidence concerns the gene CD4 and lymphoma.